{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T06:28:16Z","timestamp":1769063296725,"version":"3.49.0"},"reference-count":100,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Science, ICT &amp; Future Planning"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Nonalcoholic fatty liver disease (NAFLD) is found in up to 30% of the world\u2019s population and can lead to hepatocellular carcinoma (HCC), which has a poor 5-year relative survival rate of less than 40%. Clinical therapeutic strategies are not very successful. The co-occurrence of metabolic disorders and inflammatory environments during the development of steatohepatitis thus needs to be more specifically diagnosed and treated to prevent fatal HCC development. To improve diagnostic and therapeutic strategies, the identification of molecules and\/or pathways responsible for the initiation and progression of chronic liver disease has been explored in many studies, but further study is still required. Transmembrane 4 L six family member 5 (TM4SF5) has been observed to play roles in the regulation of metabolic functions and activities in hepatocytes using in vitro cell and in vivo animal models without or with TM4SF5 expression in addition to clinical liver tissue samples. TM4SF5 is present on the membranes of different organelles or vesicles and cooperates with transporters for fatty acids, amino acids, and monocarbohydrates, thus regulating nutrient uptake into hepatocytes and metabolism and leading to phenotypes of chronic liver diseases. In addition, TM4SF5 can remodel the immune environment by interacting with immune cells during TM4SF5-mediated chronic liver diseases. Because TM4SF5 may act as an NAFLD biomarker, this review summarizes crosstalk between TM4SF5 and nutrient transporters in hepatocytes, which is related to chronic liver diseases.<\/jats:p>","DOI":"10.3390\/ijms23158387","type":"journal-article","created":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T23:37:29Z","timestamp":1659310649000},"page":"8387","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["TM4SF5-Mediated Regulation of Hepatocyte Transporters during Metabolic Liver Diseases"],"prefix":"10.3390","volume":"23","author":[{"given":"Ji Eon","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Pharmacy, College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunmi","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2722-8200","authenticated-orcid":false,"given":"Jung Weon","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/TP.0000000000002484","article-title":"Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation","volume":"103","author":"Younossi","year":"2019","journal-title":"Transplant"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: A systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s10620-011-1994-2","article-title":"Genetic variation in the peroxisome proliferator activated receptor-gamma gene is associated with histologically advanced NAFLD","volume":"57","author":"Gawrieh","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3892\/etm.2020.9154","article-title":"Abnormal metabolic processes involved in the pathogenesis of non-alcoholic fatty liver disease (Review)","volume":"20","author":"Shao","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1110\/ps.9.8.1594","article-title":"The L6 membrane proteins\u2014A new four-transmembrane superfamily","volume":"9","author":"Wright","year":"2000","journal-title":"Protein Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/bs.ircmb.2015.06.004","article-title":"Transmembrane 4 L Six Family Member 5 (TM4SF5)-Mediated Epithelial-Mesenchymal Transition in Liver Diseases","volume":"319","author":"Lee","year":"2015","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"101451","DOI":"10.1016\/j.molmet.2022.101451","article-title":"Crosstalk between TM4SF5 and GLUT8 regulates fructose metabolism in hepatic steatosis","volume":"58","author":"Lee","year":"2022","journal-title":"Mol. Metab."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s12276-019-0363-7","article-title":"Amino acid transporters as tetraspanin TM4SF5 binding partners","volume":"52","author":"Jung","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"110018","DOI":"10.1016\/j.celrep.2021.110018","article-title":"TM4SF5-dependent crosstalk between hepatocytes and macrophages to reprogram the inflammatory environment","volume":"37","author":"Kim","year":"2021","journal-title":"Cell Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"109004","DOI":"10.1016\/j.abb.2021.109004","article-title":"Tetraspanin TM4SF5 in hepatocytes negatively modulates SLC27A transporters during acute fatty acid supply","volume":"710","author":"Park","year":"2021","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1182\/blood-2008-05-160671","article-title":"Cooperation between integrin \u03b15 and tetraspan TM4SF5 regulates VEGF-mediated angiogenic activity","volume":"113","author":"Choi","year":"2009","journal-title":"Blood"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41419-019-1878-5","article-title":"TM4SF5-mediated CD44v8-10 splicing variant promotes survival of type II alveolar epithelial cells during idiopathic pulmonary fibrosis","volume":"10","author":"Kim","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00018-021-04051-x","article-title":"TM4SF5-mediated liver malignancy involves NK cell exhaustion-like phenotypes","volume":"79","author":"Sun","year":"2021","journal-title":"Cell Mol. Life Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1242\/jcs.114.23.4143","article-title":"Complexes of tetraspanins with integrins: More than meets the eye","volume":"114","author":"Berditchevski","year":"2001","journal-title":"J. Cell Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0006-291X(03)00545-X","article-title":"Multiple levels of interactions within the tetraspanin web","volume":"304","author":"Charrin","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nrm1736","article-title":"Tetraspanin functions and associated microdomains","volume":"6","author":"Hemler","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1600-0854.2006.00515.x","article-title":"Tetraspanins as regulators of protein trafficking","volume":"8","author":"Berditchevski","year":"2007","journal-title":"Traffic"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1111\/bph.12260","article-title":"Tetraspanins as regulators of the tumour microenvironment: Implications for metastasis and therapeutic strategies","volume":"171","author":"Detchokul","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.tcb.2009.06.004","article-title":"Tetraspanin-enriched microdomains: A functional unit in cell plasma membranes","volume":"19","author":"Barreiro","year":"2009","journal-title":"Trends Cell Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1096\/fj.201600944RR","article-title":"Dynamic and coordinated single-molecular interactions at TM4SF5-enriched microdomains guide invasive behaviors in 2- and 3-dimensional environments","volume":"31","author":"Kim","year":"2017","journal-title":"FASEB J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.lungcan.2015.06.023","article-title":"Bidirectional signaling between TM4SF5 and IGF1R promotes resistance to EGFR kinase inhibitors","volume":"90","author":"Choi","year":"2015","journal-title":"Lung Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1128\/MCB.00660-14","article-title":"Cross Talk between the TM4SF5\/Focal Adhesion Kinase and the Interleukin-6\/STAT3 Pathways Promotes Immune Escape of Human Liver Cancer Cells","volume":"34","author":"Ryu","year":"2014","journal-title":"Mol. Cell Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1016\/j.yexcr.2006.06.001","article-title":"Focal adhesion and actin organization by a cross-talk of TM4SF5 with integrin alpha2 are regulated by serum treatment","volume":"312","author":"Lee","year":"2006","journal-title":"Exp. Cell Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.cmet.2019.03.005","article-title":"Transmembrane 4 L Six Family Member 5 Senses Arginine for mTORC1 Signaling","volume":"29","author":"Jung","year":"2019","journal-title":"Cell Metab."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00535-008-2193-6","article-title":"Liver diseases and metabolic syndrome","volume":"43","author":"Watanabe","year":"2008","journal-title":"J. Gastroenterol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1053\/j.gastro.2017.07.001","article-title":"Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men with Chronic Hepatitis B: A Large Cohort Study","volume":"153","author":"Yu","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"100479","DOI":"10.1016\/j.jhepr.2022.100479","article-title":"Lipid alterations in chronic liver disease and liver cancer","volume":"4","author":"Paul","year":"2022","journal-title":"JHEP. Rep."},{"key":"ref_28","unstructured":"Feingold, K.R., Anawalt, B., Boyce, A., Chrousos, G., de Herder, W.W., Dhatariya, K., Dungan, K., Hershman, J.M., Hofland, J., and Kalra, S. (2000). Lipid and Lipoprotein Metabolism in Liver Disease. Endotext, MDText.com, Inc."},{"key":"ref_29","first-page":"e21369","article-title":"SLAC2B-dependent microtubule acetylation regulates extracellular matrix-mediated intracellular TM4SF5 traffic to the plasma membranes","volume":"35","author":"Kim","year":"2021","journal-title":"FASEB J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.1242\/jcs.100586","article-title":"Tetraspan TM4SF5-dependent direct activation of FAK and metastatic potential of hepatocarcinoma cells","volume":"125","author":"Jung","year":"2012","journal-title":"J. Cell Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2018.08.001","article-title":"Role of DGAT enzymes in triacylglycerol metabolism","volume":"655","author":"Jordan","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.bbalip.2011.09.017","article-title":"Fatty acid synthase and liver triglyceride metabolism: Housekeeper or messenger?","volume":"1821","author":"Semenkovich","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/187152209788009850","article-title":"Targeting the fatty acid transport proteins (FATP) to understand the mechanisms linking fatty acid transport to metabolism","volume":"9","author":"Black","year":"2009","journal-title":"Immunol. Endocr. Metab. Agents Med. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1161\/ATVBAHA.114.304584","article-title":"Roles of Acyl-CoA:Diacylglycerol Acyltransferases 1 and 2 in Triacylglycerol Synthesis and Secretion in Primary Hepatocytes","volume":"35","author":"Li","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"bqz046","DOI":"10.1210\/endocr\/bqz046","article-title":"CPT1A-mediated Fat Oxidation, Mechanisms, and Therapeutic Potential","volume":"161","author":"Schlaepfer","year":"2020","journal-title":"Endocrinology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/path.5548","article-title":"Differential TM4SF5-mediated SIRT1 modulation and metabolic signaling in nonalcoholic steatohepatitis progression","volume":"253","author":"Ryu","year":"2021","journal-title":"J. Pathol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev-nutr-071812-161139","article-title":"Fatty acid-regulated transcription factors in the liver","volume":"33","author":"Jump","year":"2013","journal-title":"Annu. Rev. Nutr."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1210\/me.2002-0190","article-title":"Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARs suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling","volume":"17","author":"Yoshikawa","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13059-018-1439-8","article-title":"Hepatic steatosis risk is partly driven by increased de novo lipogenesis following carbohydrate consumption","volume":"19","author":"Sanders","year":"2018","journal-title":"Genome Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.metabol.2014.04.003","article-title":"De novo lipogenesis in health and disease","volume":"63","author":"Ameer","year":"2014","journal-title":"Metabolism"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/brv.12178","article-title":"De novo lipogenesis in the liver in health and disease: More than just a shunting yard for glucose","volume":"91","author":"Sanders","year":"2016","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1007\/s10620-016-4054-0","article-title":"Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease","volume":"61","author":"Softic","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.mce.2016.12.022","article-title":"Hepatic lipid metabolism and non-alcoholic fatty liver disease in aging","volume":"455","author":"Gong","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1007\/s11427-019-1563-3","article-title":"Regulation of glucose and lipid metabolism in health and disease","volume":"62","author":"Chen","year":"2019","journal-title":"Sci. China Life Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.clnesp.2019.07.004","article-title":"Fructose, galactose and glucose-In health and disease","volume":"33","author":"Qi","year":"2019","journal-title":"Clin. Nutr. ESPEN"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.3748\/wjg.v18.i46.6771","article-title":"Hepatic expression and cellular distribution of the glucose transporter family","volume":"18","author":"Karim","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Mao, Z., and Zhang, W. (2018). Role of mTOR in Glucose and Lipid Metabolism. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19072043"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1139\/bcb-2018-0004","article-title":"mTOR signalling: Jack-of-all-trades","volume":"97","author":"Egom","year":"2019","journal-title":"Biochem. Cell Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1073\/pnas.0914798107","article-title":"Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis","volume":"107","author":"Li","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s13238-017-0409-3","article-title":"mTORC1 signaling in hepatic lipid metabolism","volume":"9","author":"Han","year":"2018","journal-title":"Protein Cell"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"bqac041","DOI":"10.1210\/endocr\/bqac041","article-title":"Targeting mTOR in the Context of Diet and Whole-body Metabolism","volume":"163","author":"Koundouros","year":"2022","journal-title":"Endocrinology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cmet.2017.07.001","article-title":"The Dawn of the Age of Amino Acid Sensors for the mTORC1 Pathway","volume":"26","author":"Wolfson","year":"2017","journal-title":"Cell Metab."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1126\/science.1257132","article-title":"Metabolism. Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1","volume":"347","author":"Wang","year":"2015","journal-title":"Science"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.cell.2017.09.046","article-title":"mTORC1 Activator SLC38A9 Is Required to Efflux Essential Amino Acids from Lysosomes and Use Protein as a Nutrient","volume":"171","author":"Wyant","year":"2017","journal-title":"Cell"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13578-020-00396-1","article-title":"mTOR signaling pathway and mTOR inhibitors in cancer: Progress and challenges","volume":"10","author":"Zou","year":"2020","journal-title":"Cell Biosci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1172\/JCI33768","article-title":"Tetraspanin TM4SF5 mediates loss of contact inhibition through epithelial-mesenchymal transition in human hepatocarcinoma","volume":"118","author":"Lee","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.omto.2022.01.006","article-title":"Therapeutic effects of TM4SF5-targeting chimeric and humanized monoclonal antibodies in hepatocellular and colon cancer models","volume":"24","author":"Ko","year":"2022","journal-title":"Mol. Ther. Oncolytics"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1161\/01.CIR.0000066909.13953.F1","article-title":"Critical role of L-arginine in endothelial cell survival during oxidative stress","volume":"107","author":"Suschek","year":"2003","journal-title":"Circulation"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nature15529","article-title":"Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis","volume":"527","author":"Rabinovich","year":"2015","journal-title":"Nature"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2015.04.020","article-title":"Targeting arginine metabolism pathway to treat arginine-dependent cancers","volume":"364","author":"Qiu","year":"2015","journal-title":"Cancer Lett."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/hep.22777","article-title":"Blockade of four-transmembrane L6 family member 5 (TM4SF5)-mediated tumorigenicity in hepatocytes by a synthetic chalcone derivative","volume":"49","author":"Lee","year":"2009","journal-title":"Hepatology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"594","DOI":"10.7150\/thno.15629","article-title":"Anti-cancer activity of novel TM4SF5-targeting antibodies through TM4SF5 neutralization and immune cell-mediated cytotoxicity","volume":"7","author":"Ahn","year":"2017","journal-title":"Theranostics"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"151229","DOI":"10.1016\/j.ejcb.2022.151229","article-title":"Tetraspanins interweave EV secretion, endosomal network dynamics and cellular metabolism","volume":"101","author":"Toribio","year":"2022","journal-title":"Eur. J. Cell Biol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fcell.2019.00097","article-title":"Integration Through Separation-The Role of Lateral Membrane Segregation in Nutrient Uptake","volume":"7","author":"Busto","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"723341","DOI":"10.3389\/fonc.2021.723341","article-title":"Role of Tetraspanins in Hepatocellular Carcinoma","volume":"11","author":"Cai","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.2741\/3818","article-title":"Modulation of signaling between TM4SF5 and integrins in tumor microenvironment","volume":"16","author":"Lee","year":"2011","journal-title":"Front. Biosci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1517\/14728222.2012.712688","article-title":"Targeting tetraspanins in cancer","volume":"16","author":"Ailane","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e21848","DOI":"10.1096\/fj.202002602R","article-title":"The role of lysosomal membrane proteins in glucose and lipid metabolism","volume":"35","author":"Gu","year":"2021","journal-title":"FASEB J."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/tra.12705","article-title":"Energetic adaptations: Metabolic control of endocytic membrane traffic","volume":"20","author":"Rahmani","year":"2019","journal-title":"Traffic"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/jcp.21384","article-title":"The tetraspanin CD9 modulates epidermal growth factor receptor signaling in cancer cells","volume":"216","author":"Murayama","year":"2008","journal-title":"J. Cell Physiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1242\/jcs.00793","article-title":"Tetraspanin CD82 regulates compartmentalisation and ligand-induced dimerization of EGFR","volume":"116","author":"Odintsova","year":"2003","journal-title":"J. Cell Sci."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Huang, W., Febbraio, M., and Silverstein, R.L. (2011). CD9 tetraspanin interacts with CD36 on the surface of macrophages: A possible regulatory influence on uptake of oxidized low density lipoprotein. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0029092"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12964-021-00730-1","article-title":"The exosome journey: From biogenesis to uptake and intracellular signalling","volume":"19","author":"Gurung","year":"2021","journal-title":"Cell Commun. Signal."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s13046-018-0961-6","article-title":"Tspan8 and Tspan8\/CD151 knockout mice unravel the contribution of tumor and host exosomes to tumor progression","volume":"37","author":"Zhao","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"627424","DOI":"10.3389\/fimmu.2020.627424","article-title":"Extracellular Vesicles as Inflammatory Drivers in NAFLD","volume":"11","author":"Srinivas","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1111\/jgh.13065","article-title":"Hepatocytes in liver injury: Victim, bystander, or accomplice in progressive fibrosis?","volume":"30","author":"Tu","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_77","first-page":"113","article-title":"Kinetics of the inflammatory response induced by free fatty acid accumulation in hepatocytes","volume":"13","author":"Rosso","year":"2013","journal-title":"Ann. Hepatol."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Puengel, T., Liu, H., Guillot, A., Heymann, F., Tacke, F., and Peiseler, M. (2022). Nuclear Receptors Linking Metabolism, Inflammation, and Fibrosis in Nonalcoholic Fatty Liver Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23052668"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"708959","DOI":"10.3389\/fimmu.2021.708959","article-title":"Crosstalk Between Plasma Cytokines, Inflammation, and Liver Damage as a New Strategy to Monitoring NAFLD Progression","volume":"12","author":"Mattos","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1053\/j.gastro.2014.06.043","article-title":"Roles for chemokines in liver disease","volume":"147","author":"Marra","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_81","first-page":"42","article-title":"Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma","volume":"5","author":"Raza","year":"2019","journal-title":"Hepatoma Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1742-4658.2011.08452.x","article-title":"Antagonistic regulation of transmembrane 4 L6 family member 5 attenuates fibrotic phenotypes in CCl(4) -treated mice","volume":"279","author":"Kang","year":"2012","journal-title":"FEBS J."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"5108525","DOI":"10.1155\/2017\/5108525","article-title":"TM4SF5-Mediated Roles in the Development of Fibrotic Phenotypes","volume":"2017","author":"Ryu","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1111\/febs.15877","article-title":"Liver macrophages and inflammation in physiology and physiopathology of non-alcoholic fatty liver disease","volume":"289","author":"Thibaut","year":"2022","journal-title":"FEBS J."},{"key":"ref_85","first-page":"5187","article-title":"Clinicopathological significance of TM4SF5 expression in human hepatocellular carcinoma tissues","volume":"17","author":"Xu","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1634\/theoncologist.2019-IO-S1-s01","article-title":"Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Opportunities and Challenges","volume":"24","author":"Liu","year":"2019","journal-title":"Oncologist"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41575-019-0144-8","article-title":"Past, present and future perspectives in nonalcoholic fatty liver disease","volume":"16","author":"Sanyal","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-021-03362-0","article-title":"NASH limits anti-tumour surveillance in immunotherapy-treated HCC","volume":"592","author":"Pfister","year":"2021","journal-title":"Nature"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"9729107","DOI":"10.1155\/2017\/9729107","article-title":"Diagnostic Value of CK-18, FGF-21, and Related Biomarker Panel in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis","volume":"2017","author":"He","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1155\/2014\/757929","article-title":"Biomarkers in nonalcoholic fatty liver disease","volume":"28","author":"Neuman","year":"2014","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"704704","DOI":"10.3389\/fcell.2021.704704","article-title":"Comprehensive Analysis of NAFLD and the Therapeutic Target Identified","volume":"9","author":"Wen","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jhep.2014.07.006","article-title":"CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis","volume":"61","author":"Zhang","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jhep.2006.02.011","article-title":"Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2","volume":"44","author":"Haukeland","year":"2006","journal-title":"J. Hepatol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1042\/BST0390512","article-title":"Tetraspanins in the humoral immune response","volume":"39","year":"2011","journal-title":"Biochem. Soc. Trans."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1042\/BST20110745","article-title":"The emerging role of tetraspanin microdomains on endothelial cells","volume":"39","author":"Bailey","year":"2011","journal-title":"Biochem. Soc. Trans."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"G138","DOI":"10.1152\/ajpgi.00411.2016","article-title":"CD151 supports VCAM-1-mediated lymphocyte adhesion to liver endothelium and is upregulated in chronic liver disease and hepatocellular carcinoma","volume":"313","author":"Wadkin","year":"2017","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/jcmm.16167","article-title":"CD63 negatively regulates hepatocellular carcinoma development through suppression of inflammatory cytokine-induced STAT3 activation","volume":"25","author":"Yu","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"183296","DOI":"10.1016\/j.bbamem.2020.183296","article-title":"Hepatitis C virus infection and tight junction proteins: The ties that bind","volume":"1862","author":"Mailly","year":"2020","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1042\/bj20030343","article-title":"EWI-2 is a new component of the tetraspanin web in hepatocytes and lymphoid cells","volume":"373","author":"Charrin","year":"2003","journal-title":"Biochem. J."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jhep.2006.08.011","article-title":"Overexpression of the gene for transmembrane 4 superfamily member 4 accelerates liver damage in rats treated with CCl4","volume":"46","author":"Qiu","year":"2007","journal-title":"J. Hepatol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/15\/8387\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:58:57Z","timestamp":1760140737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/15\/8387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,29]]},"references-count":100,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["ijms23158387"],"URL":"https:\/\/doi.org\/10.3390\/ijms23158387","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,29]]}}}